Evan David Seigerman
Stock Analyst at BMO Capital
(0.4)
# 2524
Out of 5,344 analysts
49
Total ratings
18.42%
Success rate
4.82%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
MRUS Merus | Maintains: Outperform | 96 110 | 55.14 | 99.49% | 1 | May 23, 2025 | |
NGNE Neurogene | Maintains: Outperform | 16 22 | 17.3 | 27.17% | 1 | May 20, 2025 | |
ACAD ACADIA Pharmaceutica... | Maintains: Outperform | 24 28 | 22 | 27.27% | 1 | May 19, 2025 | |
ARVN Arvinas | Maintains: Outperform | 20 10 | 6.53 | 53.14% | 1 | May 5, 2025 | |
REGN Regeneron Pharmaceut... | Maintains: Outperform | 865 800 | 588.66 | 35.9% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 105 64 | 67.25 | -4.83% | 6 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 105 96 | 77.57 | 23.76% | 4 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 208 215 | 183.52 | 17.15% | 7 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 362 346 | 272.08 | 27.17% | 4 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 27 | 8.36 | 222.97% | 3 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 52 57 | n/a | n/a | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 83 100 | 24.57 | 307% | 2 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 33 36 | 23.32 | 54.37% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 31 72 | n/a | n/a | 4 | Oct 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 3 | 5.45 | -44.95% | 1 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 369 396 | 713.52 | -44.5% | 1 | Sep 6, 2022 |